CDC Opioid Prescribing Guidelines and APRN Practice Plan
This paper summarizes the CDC's 2016 guidelines for prescribing opioids to treat chronic pain in adults and translates those guidelines into a practical management plan for Advanced Practice Registered Nurses (APRNs). The paper covers three core guideline domains: determining when to initiate opioid therapy, selecting appropriate dosages and duration, and assessing and mitigating risks such as overdose and diversion. It then outlines a four-stage Standard of Care framework for APRNs, an opioid prescription schedule spanning acute, subacute, and chronic pain phases, co-prescribing restrictions, alternative pain management modalities, and patient notification requirements.
- Introduction: Opioid crisis context and paper scope
- Summary of CDC Guidelines on Opioid Prescribing: When to initiate opioids and treatment goals
- Opioid Selection, Dosage, Duration, and Discontinuation: Dosage rules, duration limits, and tapering
- Risk Assessment and Managing Negative Effects: Harm screening, PDMP, urine testing, benzodiazepines
- APRN Opioid Management Plan: Four-stage Standard of Care framework for APRNs
- Opioid Prescription Schedule and Co-Prescribing Rules: Acute, subacute, and chronic pain prescribing steps
- Alternative Modalities, Consultation, and Patient Notification: Non-opioid options, specialist consultation, patient rights
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Clearly maps abstract CDC policy language onto concrete clinical steps, making the guidelines immediately actionable for APRN readers.
- Uses a numbered, staged structure that mirrors real clinical workflow — from patient evaluation through ongoing treatment — which aids comprehension and memorability.
- The prescription schedule table (acute / subacute / chronic) distills complex timing guidance into a scannable reference format that practitioners can apply directly.
- Appropriately limits scope to the CDC's own stated coverage area (adults 18+, outpatient settings) and explicitly notes exclusions such as cancer pain and palliative care.
Key academic technique demonstrated
The paper demonstrates effective policy synthesis: it condenses a lengthy federal clinical guideline into its operative principles, then applies those principles to a specific professional context (APRN practice). Each recommendation is traceable to a named source, showing how practitioners should ground clinical decision-making in evidence-based standards rather than experience alone.
Structure breakdown
The paper opens with epidemiological context establishing the opioid crisis, then moves through three CDC guideline domains (initiation, dosage, risk), followed by a four-stage APRN Standard of Care framework. The final sections shift to a practical prescription schedule organized by pain phase, co-prescribing rules, alternative modalities, and patient notification requirements — ending with a full reference list in APA format.
Introduction
From 1999 to 2014, the number of prescription opioids dispensed in the United States quadrupled. Despite this dramatic increase, there was no corresponding evidence of a reduction in the pain patients experienced. Instead, opioid overdose deaths rose at roughly the same rate as prescriptions. The Centers for Disease Control and Prevention (CDC) provides safety guidelines for the prescription of opioids for pain relief in persons aged 18 years and above in outpatient settings — that is, outside medical care facilities such as palliative care centers and end-of-life care settings (CDC, 2016). This paper summarizes the CDC guidelines on opioid prescribing for chronic pain and outlines a management plan for opioid prescribing as an Advanced Practice Registered Nurse (APRN).
Summary of CDC Guidelines on Opioid Prescribing
Determining When to Start or Continue Opioids for Chronic Pain
1. Opioids Are Not a First-Line or Routine Therapy for Chronic Pain
Chronic pain is best managed with nonpharmacologic and non-opioid therapies. Clinicians should consider opioid treatment only when the expected benefits outweigh the risks to the patient. When opioids are prescribed, they should be offered alongside nonpharmacologic and non-opioid therapies as the clinical situation demands (Dowell, Haegerich, & Chou, 2016).
2. Establish and Measure Progress Toward Treatment Goals
Before initiating opioid therapy for chronic pain, healthcare providers should establish treatment goals collaboratively with the patient. These goals should be realistic and should address both pain relief and functional improvement. Consideration should be given from the outset to how therapy will be discontinued if the risks are found to outweigh the benefits.
Before opioid therapy begins, and periodically throughout, there should be open discussion between the clinician and patient about the risks and realistic benefits of the chosen therapy. The responsibilities of both the clinician and the patient during therapy should also be clearly discussed (Dowell et al., 2016).
Opioid Selection, Dosage, Duration, and Discontinuation
1. Use Immediate-Release Opioids at the Onset of Therapy
Clinicians should prescribe only immediate-release opioids when initiating opioid therapy, rather than extended-release formulations.
2. Exercise Caution at Every Dosage Level
Clinicians should remain cautious at any dosage and should avoid raising doses unnecessarily.
3. Start with the Lowest Effective Dose
Clinicians should begin with the lowest effective dosage. Benefits must be carefully documented as opioids are administered. Risks must also be documented if and when the dosage is increased to 50 morphine milligram equivalents (MME) per day, and escalation to 90 MME per day should be avoided. Any titration to 90 MME or above must be explicitly justified in the clinical record.
4. Avoid Prescribing More Than Is Needed
Long-term opioid use often begins with acute pain treatment. When opioids are used to alleviate acute pain, providers should prescribe the lowest effective immediate-release dose and should not increase it beyond what is required for the treatment period. In most cases, three days of opioid administration will suffice; the duration should never exceed seven days under any circumstances.
5. Taper Opioids When They Are Ineffective or Harmful
Healthcare providers should evaluate the effects of opioids within one to four weeks of dose escalation. The benefits and adverse effects of opioid therapy should be reviewed every three months or sooner (Dowell et al., 2016). If the harms of continued opioid use outweigh the benefits, a clear discontinuation plan should be implemented using tapering strategies to reduce the medication gradually.
APRN Opioid Management Plan
APRNs who manage patients experiencing pain are typically certified nurse practitioners. Like many family practice physicians, they may not have received specialized training in professional pain management (Institute of Medicine, 2011). In fact, more than 50% of opioid prescriptions are written by healthcare providers — particularly certified nurse practitioners — who lack expert pain management education (Breuer, Cruciani, & Portenoy, 2010; Hudspeth, 2016). Such providers may find themselves making clinical decisions based on practical experience rather than on vetted, accepted standards of care (SOCs). This can lead to counterproductive outcomes, including opioid diversion or fatal overdoses, which may ultimately result in complaints to the Board of Nursing (BON).
Using the Standard of Care (SoC) for APRNs
The Standard of Care provides a framework for APRNs to evaluate pain management across four stages of the care process.
Stage 1: Physical and History Assessment
From the healthcare record, the clinician should extract interview notes and the history of the illness or injury causing the pain, including details of any mitigating interventions and comorbidities. The assessment should incorporate referrals, treatment reports, opioid abuse screening results, PDMP reports, therapies, laboratory results, urine drug test outcomes, and imaging findings (Hudspeth, 2016). Validated screening tools should be used consistently and relied upon for accuracy.
Stage 2: Decision to Initiate Opioid Treatment
The practitioner must obtain an informed consent document signed by both the APRN and the patient or their guardian. This document serves as evidence that the benefits and risks of opioid therapy have been discussed and understood (Cheatle & Savage, 2012). The recognized benefits of opioid treatment include achieving a level of functional well-being that allows the patient to carry out basic daily activities.
Stage 3: Trial of Opioid Prescription
The initial treatment course should be treated as a therapeutic assessment with defined goals, treatment parameters, and decision-making guidelines. The opioid dosage may be adjusted during the trial, or the prescription may be changed from one opioid agent to another — for example, from morphine to oxycodone.
Stage 4: Ongoing Treatment and Evaluation
Most clinical problems surface during this stage. Familiarity with a patient over time can lead an APRN to become less vigilant, causing them to overlook important warning signs. APRNs are therefore encouraged to maintain thorough care and documentation at every stage of treatment (Hudspeth, 2016). Self-reported pain ratings should be collected at each visit. Any attempt to reduce or increase dosage should be supported by well-documented clinical justification, particularly for dose increases.
References
Breuer, B., Cruciani, R., & Portenoy, R. K. (2010). Pain management by primary care physicians, pain physicians, chiropractors, and acupuncturists: A national survey. Southern Medical Journal, 103(8), 738–747.
CDC. (2016). CDC guideline for prescribing opioids for chronic pain. Center for Preparedness and Response.
Cheatle, M. D., & Savage, S. R. (2012). Informed consent in opioid therapy: A potential obligation and opportunity. Journal of Pain and Symptom Management, 44(1), 105–116.
Dowell, D., Haegerich, T. M., & Chou, R. (2016). CDC guideline for prescribing opioids for chronic pain — United States, 2016. JAMA, 315(15), 1624–1645.
Hudspeth, R. S. (2016). Standards of care for opioid prescribing: What every APRN prescriber and investigator needs to know. Journal of Nursing Regulation, 7(1), 15–20.
Institute of Medicine. (2011). Relieving pain in America: A blueprint for transforming prevention, care, education, and research. National Academies Press.
Create your account
Always verify citation format against your institution’s current style guide requirements.